Search results
Showing 4261 to 4275 of 8930 results
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (HTG292)
Evidence-based recommendations on 3 electroencephalography (EEG)-based depth of anaesthesia monitors for assessing a patient’s response to anaesthetic drugs during surgery. The monitors are Bispectral Index (BIS), E-Entrophy and Narcotrend-Compact M.
Home Events...
Read NICE's statement on modern slavery and human trafficking.
We support the wellbeing of our staff in a number of ways including an employee assistance programme, mental health first aiders and a variety of health and wellbeing activities.
We want people from all walks of life to contribute to our work and share their experience, expertise and passion.
Find out which guidance and quality standards are awaiting development
Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis
Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.
Find out what guidance is being considered for development
See a complete list of all our guidance and quality standards currently open for consultation
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards
View a complete list of all our guidance, NICE advice and quality standards currently in development
Supporting the health and care system to implement virtual wards
Virtual wards (also known as hospital at home) provide hospital level care at home.
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.